| 000 | 01895 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516145554.0 | ||
| 264 | 0 | _c20130926 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a0006-3002 | ||
| 024 | 7 |
_a10.1016/j.bbapap.2013.04.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJesse, Helen E | |
| 245 | 0 | 0 |
_aCytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo'' to inhibition by the carbon monoxide-releasing molecule, CORM-3: N-acetylcysteine reduces CO-RM uptake and inhibition of respiration. _h[electronic resource] |
| 260 |
_bBiochimica et biophysica acta _cSep 2013 |
||
| 300 |
_a1693-703 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aCarbon Monoxide _xmetabolism |
| 650 | 0 | 4 |
_aCell Membrane _xdrug effects |
| 650 | 0 | 4 |
_aCell Respiration _xdrug effects |
| 650 | 0 | 4 | _aCytochrome b Group |
| 650 | 0 | 4 |
_aCytochromes _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aElectron Transport Chain Complex Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aEscherichia coli _xmetabolism |
| 650 | 0 | 4 |
_aEscherichia coli Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHeme _xmetabolism |
| 650 | 0 | 4 | _aHyperbaric Oxygenation |
| 650 | 0 | 4 |
_aLeghemoglobin _xmetabolism |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xpharmacology |
| 650 | 0 | 4 |
_aOxidoreductases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
| 650 | 0 | 4 |
_aRuthenium _xpharmacology |
| 700 | 1 | _aNye, Tacita L | |
| 700 | 1 | _aMcLean, Samantha | |
| 700 | 1 | _aGreen, Jeffrey | |
| 700 | 1 | _aMann, Brian E | |
| 700 | 1 | _aPoole, Robert K | |
| 773 | 0 |
_tBiochimica et biophysica acta _gvol. 1834 _gno. 9 _gp. 1693-703 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbapap.2013.04.019 _zAvailable from publisher's website |
| 999 |
_c22706033 _d22706033 |
||